Featured
Want to learn more about Benefit-Risk Assessment from Inception to Maturation: Aligning Regulatory and Industry Goals ? You've come to the right site!
Program Committee
-
K. Kimberly McCleary Founder and Chief Executive Officer
The Kith Collective, LLC, United States -
Rebecca Noel, DrPH, MPH Executive Director, Benefit-Risk Assessment
Eli Lilly, United States -
Bennett Levitan, MD, PHD Executive Director, Benefit-Risk Assessment / Epidemiology
Johnson & Johnson, United States -
Marilyn A. Metcalf, PHD Senior Director, Patient Focused Development, Global Medical
GlaxoSmithKline, United States -
Lawrence Liberti, PHD, RAC Director, D.K. Kim International Center for Regulatory Science
The Kim Center/ USC DRQS, United States
Have an account?